LIU Yuling
Principal Investigator
Liu Yuling is a tenured professor, research fellow, and doctoral supervisor at the Institute of Pharmaceutical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, head of the Department of Pharmacy, director of the Department of Pharmaceutics, and director of the Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation.
She has presided over several national and provincial major fund projects. She received over 10 new drug certificates for projects she led. She has trained over 50 master and doctoral students and published over 100 papers including over 40 SCI-indexed papers, with more than 40 patents granted. She has won five national, Beijing, and Chinese Medical Association Science and Technology awards.
1. Oral SMEDDS Promotes Lymphatic Transport and Mesenteric Lymph Nodes Target of Chlorogenic Acid for Effective T-cell Antitumor Immunity. Journal for Immuno Therapy of Cancer , 2021.
2.Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations. Journal of Nanobiotechnology, 2021,19(1):199. Doi:10.1186/s12951-021-00946-w.
3. The main bioactive compounds of Scutellaria baicalensis Georgi. for alleviation of inflammatory cytokine: A comprehensive review. Biomedicine & Pharmacotherapy , 2021, 133:110917.
4. Construction of chlorogenic acid-containing liposomes with prolonged antitumor inmunity based on T cell regulation. Science China life Sciences , 2021, 64(7):1097-1115.
5. Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma. Bioactive Materials , 2020, 5(3):694-708.
6. Comparative study of mucoadhesive and mucus-penetrative nanoparticles based on phospholipid complex to overcome the mucus barrier for inhaled delivery of baicalein. Acta Pharmaceutica Sinica B , 2020, 10(8):1576-1585.
7. Self-Assembled Lecithin/ Chitosan Nanoparticles Based on Phospholipid Complex：A Feasible strategy to Improve Entrapment Efficiency and Transdermal Delivery of poorly Lipophilic Drug. International Journal of Nanomedicine , 2020, 15:5629-5643.
8. Improving the Oral Bioavailability of an Anti‐Glioma Prodrug CAT3 Using Novel Solid Lipid Nanoparticles Containing Oleic Acid CAT3 Conjugates. Pharmaceutics , 2020, 12(2):126.
9. Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophage. International Journal of Nanomedicine ，2019, 14:3203-3220.
10. Oral absorption and lymphatic transport of baicalein following drug–phospholipid complex incorporation in self-microemulsifying drug delivery systems. International Journal of Nanomedicine ，2019, 14:7291-7306.
1. Pharmacology of new drugs. Edited by Xiaoguang Chen, Yan Li, Yuling Liu and so on. China Union Medical University Press.
2. Precision research and development of natural drugs. Edited by Shishan Yu, Xiaoguang Chen, Jiangong Shi, Yuling Liu and so on. Shanghai Jiaotong University Press ，Pages 188-207. Print ISBN:978-7-313.
1. 2009, Second prize, National Science and Technology Progress.
2. 2009, Third prize, the Beijing Science and Technology Progress Award.
3. 2009, Third prize, Chinese Medical Science and Technology.
4. 2005, First prize, the Beijing Science and Technology Progress Award.
5. 2005, Second prize, Chinese Medical Science and Technology.
6. 2020, the Second National Innovation Award.
7. 2020, the 9th National Expert for Outstanding Contribution to Health.
8. 2016, one of the top ten people of Beijing Capital Science and Technology Ceremony.
